The Valley Desk

NCT03813238 · Interventional trial

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents

Overall registry status Completed

Phase 3

Conditions Cerebral Palsy, Dyskinetic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov